{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL475&answeringDeptId=17", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?identifier=HL475&answeringDeptId=17", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL475&answeringDeptId=17&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL475&_page=0&answeringDeptId=17", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL475&answeringDeptId=17", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?identifier=HL475&answeringDeptId=17", "items" : [{"_about" : "http://data.parliament.uk/resources/1672048", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1672048/answer", "answerText" : {"_value" : "

The Government recognises that there are issues with recruitment and retention in certain areas of the country, including some rural locations. We launched the Targeted Enhanced Recruitment Scheme in 2016, which has attracted hundreds of doctors to train in hard to recruit locations, including many rural areas, by providing a one-off financial incentive of £20,000. As of 2023/24, there are 782 places available on the scheme.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2023-11-29", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-11-29T13:59:00.543Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-11-21", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "General Practitioners: Rural Areas"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what steps they are taking to encourage more GPs to practice in rural areas.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/384", "label" : {"_value" : "Biography information for Baroness McIntosh of Pickering"} } , "tablingMemberPrinted" : [{"_value" : "Baroness McIntosh of Pickering"} ], "uin" : "HL475"} , {"_about" : "http://data.parliament.uk/resources/1465593", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1465593/answer", "answerText" : {"_value" : "

No record of a formal risk assessment is held, either on the mandatory introduction of National Health Service numbers in 1997 or following the introduction of the Gender Recognition Act in 2004.<\/p>

When a patient changes gender, they are given a new NHS number. When a patient informs their general practice that they wish to change gender, the practice must inform the patient that this will involve a new NHS number being issued, which is not reversible.<\/p>

If a patient is issued with a new NHS number, they will not automatically be recalled for certain sex-specific screening programmes. The online only guidance \u2018NHS population screening: information for trans and non-binary people\u2019 provides advice to transgender and non-binary people in England on the NHS screening programmes available in England and the processes for inviting people to screening.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4909", "label" : {"_value" : "Biography information for Lord Kamall"} } , "answeringMemberPrinted" : {"_value" : "Lord Kamall"} , "attachment" : {"_about" : "http://data.parliament.uk/resources/1465593/answer/attachment/1", "fileName" : {"_value" : "HL475- Supporting Screening page.pdf"} , "title" : "Attachment "} , "dateOfAnswer" : {"_value" : "2022-07-11", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2022-07-11T16:58:36.23Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2022-05-24", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Medical Records: Transgender People"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what form of risk assessment was carried out by (1) Public Health England, and (2) other NHS bodies, before (a) implementing a system of recording patients by their chosen gender identity rather than their biological sex, and (b) deciding to create a new stand-alone NHS record for those patients who choose to change their recorded gender identity.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3396", "label" : {"_value" : "Biography information for Lord Clement-Jones"} } , "tablingMemberPrinted" : [{"_value" : "Lord Clement-Jones"} ], "uin" : "HL475"} , {"_about" : "http://data.parliament.uk/resources/1156595", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1156595/answer", "answerText" : {"_value" : "

It has not proved possible to respond to this question in the time available before Dissolution. Ministers will correspond directly with the Member.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4019", "label" : {"_value" : "Biography information for Baroness Blackwood of North Oxford"} } , "answeringMemberPrinted" : {"_value" : "Baroness Blackwood of North Oxford"} , "dateOfAnswer" : {"_value" : "2019-11-05", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2019-11-05T17:14:39.44Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-10-28", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Vaccination: Children"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what plans, if any, they have to increase the uptake of childhood vaccinations; and when any such plans are likely to be implemented.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1796", "label" : {"_value" : "Biography information for Lord Taylor of Warwick"} } , "tablingMemberPrinted" : [{"_value" : "Lord Taylor of Warwick"} ], "uin" : "HL475"} , {"_about" : "http://data.parliament.uk/resources/748021", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/748021/answer", "answerText" : {"_value" : "

Emergency medical technicians and paramedics operate to the Joint Royal Colleges Ambulance Liaison Committee Clinical Practise Guidelines 2016. This does not refer to the use of Diphoterine. Ambulance personnel would follow the chemical, biological, radiological and nuclear advice in the guidelines to disrobe the patient and decontaminate with water.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4545", "label" : {"_value" : "Biography information for Lord O'Shaughnessy"} } , "answeringMemberPrinted" : {"_value" : "Lord O'Shaughnessy"} , "dateOfAnswer" : {"_value" : "2017-07-11", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "HL473"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2017-07-11T15:01:51.937Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2017-07-04", "_datatype" : "dateTime"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "Her Majesty's Government whether NHS protocols for the management of acid attacks include the use of Diphotrine for the purposes of emergency treatment.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1827", "label" : {"_value" : "Biography information for Baroness Uddin"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Uddin"} ], "uin" : "HL475"} , {"_about" : "http://data.parliament.uk/resources/381027", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/381027/answer", "answerText" : {"_value" : "

The National Institute for Health Care Excellence (NICE) has produced a Clinical Knowledge Summary (CKS) to support clinicians in the management of both short-term and long-term insomnia. The choice of management strategy will depend upon certain considerations, such as the duration and nature of the presenting symptoms as well the role of any pre-existing medical conditions a patient may have. Advice on appropriate routines and behaviours to encourage good sleep, such as avoiding coffee and other stimulants, should also be a key element to the overall strategy.<\/p>

<\/p>

<\/p>

<\/p>

Pharmacological interventions should only be prescribed for short durations and usually only when daytime impairment is severe. The guidance makes clear that for patients suffering from insomnia for over four weeks a referral to a cognitive behavioural therapy service should be considered. Where symptoms persist the guidance recommends referral to a sleep clinic or specialist with expertise in sleep medicine. The NICE CKS can be found at:<\/p>

<\/p>

<\/p>

<\/p>

http://cks.nice.org.uk/insomnia<\/a><\/p>

<\/p>

<\/p>

<\/p>

This information is only available as a web link.<\/p>

<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/127", "label" : {"_value" : "Biography information for Lord Prior of Brampton"} } , "answeringMemberPrinted" : {"_value" : "Lord Prior of Brampton"} , "dateOfAnswer" : {"_value" : "2015-06-29", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2015-06-29T14:42:59.933Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2015-06-15", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Insomnia"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty\u2019s Government what measures they are taking to increase the availability of therapy for insomnia patients.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1796", "label" : {"_value" : "Biography information for Lord Taylor of Warwick"} } , "tablingMemberPrinted" : [{"_value" : "Lord Taylor of Warwick"} ], "uin" : "HL475"} , {"_about" : "http://data.parliament.uk/resources/62795", "AnsweringBody" : [{"_value" : "Department of Health"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/62795/answer", "answerText" : {"_value" : "

Information is not collected centrally on the number of prescriptions written. However, information is available on the number of prescription items dispensed.<\/p>

<\/p>

A series of tables representing the four financial years 2010-11 to 2013-14, have been placed in the Library. These provide information on each of the categories of contraceptives requested, apart from intrauterine devices for the purpose of emergency contraception, as information is not held on whether intrauterine devices are for emergency or non-emergency use, however, totals for all intrauterine devices are included within the category of intrauterine systems for the purpose of contraception.<\/p>

<\/p>

The tables are based on ePACT data, representing prescriptions written in England and dispensed in the community in the United Kingdom. This does not include supply through community clinics. Information is not available for Q1 of 2010. Commissioning care group areas were formed in April 2013. Information prior to this time is in the form of primary care trusts. Contraceptives are defined products listed within British National Formulary (BNF) Section 7.3 Contraceptives<\/em>.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/2000", "label" : {"_value" : "Biography information for Earl Howe"} } , "answeringMemberPrinted" : {"_value" : "Earl Howe"} , "attachment" : {"_about" : "http://data.parliament.uk/resources/62795/answer/attachment/1", "fileName" : {"_value" : "HL475 - Lib Doc Table.xlsx"} , "title" : "Contraception prescriptions by PCT 2012-2014"} , "dateOfAnswer" : {"_value" : "2014-06-25", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2014-06-25T11:35:34.5295423Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health"} , "answeringDeptSortName" : {"_value" : "Health"} , "date" : {"_value" : "2014-06-19", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Contraceptives"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government, in each year since 2010, how many prescriptions were written for (1) oral contraceptives, (2) intrauterine systems for the purpose of contraception, (3) contraceptive injections, (4) contraceptive sub-dermal implants, (5) emergency hormonal contraceptives, and (6) intrauterine devices for the purpose of emergency contraception, in each clinical commissioning group area.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3573", "label" : {"_value" : "Biography information for Baroness Gould of Potternewton"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Gould of Potternewton"} ], "uin" : "HL475"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 6, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }